In this review, we provide an updated summary of presently identified cardiac disease entities secondary to SCN5A mutations, and give an overview of a broad spectrum of concomitant disorders and conditions which may modify disease severity and expressivity of SCN5A channelopathies. This evidence concerns the gene SCN5A and heart disorder.